Xenex debuted its infection killing robot, which utilizes UV light for disinfection, and touted a new $11.3 million financing round.
The portable UV room disinfection system "uses pulsed xenon ultraviolet light to destroy the viruses, bacteria, mold, fungus and bacterial spores in the patient environment that cause healthcare associated infections," according to a press release.
The device is designed to be inexpensive for hospitals, with no chemicals needed, and it does not disrupt hospital operations, according to a press release.
“In the United States alone, 278 people lose their lives every day from an infection they unnecessarily acquired during their hospital visit. The Xenex technology is proven and is rapidly gaining acceptance," CEO Morris Miller said in prepared remarks. "Xenex is the only company whose customers have published peer reviewed outcome studies showing a reduction in infection rates after implementing Xenex’s disinfection technology. We want to get our devices into hospitals as quickly as possible to help solve this enormous problem."
Xenex also secured $11.3 million in funding. The San Antonio-based disinfection systems company landed the money from Battery Ventures and Targeted Technology Fund II, alongside continued funding from RK Ventures.
The cash will be put towards product development, international expansion and increasing the company’s U.S. sales force.